Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 249 entries
View as:

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01850147 Org: User:
Start: 03/31/13 End: 12/31/14 Due: 12/31/15

Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03815461 Org: User:
Start: 02/01/19 End: 10/02/23 Due: 10/02/24

Characteristics and Treatment Trends of Young Breast Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT05068115 Org: User:
Start: 11/01/21 End: 10/01/24 Due: 10/01/25

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05183074 Org: User:
Start: 02/01/21 End: 01/31/24 Due: 01/31/25

Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03243825 Org: User:
Start: 11/30/12 End: 07/31/15 Due: 07/31/16

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01492556 Org: User:
Start: 12/31/11 End: 06/30/15 Due: 06/30/16

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01150513 Org: User:
Start: 06/30/09 End: 04/30/16 Due: 04/30/17

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

Phase: N/A Priority: Normal
NCT ID: NCT03947736 Org: User:
Start: 09/17/18 End: 06/30/21 Due: 06/30/22

Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Phase: N/A Priority: Normal
NCT ID: NCT02560441 Org: User:
Start: 09/30/15 End: - Due: -

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01969955 Org: User:
Start: 09/30/13 End: 06/30/15 Due: 06/30/16

The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01863420 Org: User:
Start: 11/30/12 End: 10/31/15 Due: 10/31/16

30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01156259 Org: User:
Start: 04/30/10 End: 05/31/15 Due: 05/31/16

A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01291407 Org: User:
Start: 11/30/10 End: 09/30/13 Due: 09/30/14

Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01529164 Org: User:
Start: 10/31/11 End: 09/30/14 Due: 09/30/15

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Phase: N/A Priority: Normal
NCT ID: NCT01817023 Org: User:
Start: 04/30/13 End: 03/30/21 Due: 03/30/22

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05291910 Org: User:
Start: 03/12/22 End: 12/31/25 Due: 12/31/26

Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04320979 Org: User:
Start: 05/08/20 End: 05/31/24 Due: 05/31/25

Observational Study on the Patients With Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02312284 Org: User:
Start: 01/31/11 End: 11/30/14 Due: 11/30/15

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04437160 Org: User:
Start: 02/01/20 End: 12/31/27 Due: 12/31/28

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03204032 Org: User:
Start: 10/31/16 End: 09/30/18 Due: 09/30/19

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05318339 Org: User:
Start: 03/10/22 End: 12/10/24 Due: 12/10/25

A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT01586117 Org: User:
Start: 02/29/12 End: 12/31/14 Due: 12/31/15

Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05224934 Org: User:
Start: 01/01/22 End: 12/31/24 Due: 12/31/25

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01492543 Org: User:
Start: 12/31/11 End: 10/31/14 Due: 10/31/15

HFSRT With Concurrent TMZ for Large BMs

Phase: N/A Priority: Normal
NCT ID: NCT03778541 Org: User:
Start: 12/03/18 End: 12/03/22 Due: 12/03/23